magnesium sulfate has been researched along with Muscle Weakness in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barisic, I; Drmic, D; Katancic, J; Kolenc, D; Medvidovic-Grubisic, M; Murselovic, T; Plestina-Borjan, I; Seiwerth, S; Sikiric, P; Sindic, A; Stambolija, V; Strbe, S | 1 |
Mathew, PJ; Muthurajan, N; Wig, J | 1 |
Elsais, A; Kerty, E; Melien, Ø; Popperud, TH | 1 |
3 other study(ies) available for magnesium sulfate and Muscle Weakness
Article | Year |
---|---|
Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, L-NAME and L-arginine worsen.
Topics: Amino Acid Sequence; Animals; Anti-Ulcer Agents; Arginine; Drug Therapy, Combination; Enzyme Inhibitors; HEK293 Cells; Humans; Magnesium Sulfate; Male; Muscle Weakness; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Proteins; Rats; Rats, Wistar | 2017 |
Progressive muscle weakness with respiratory insufficiency in a young patient with tetanus during magnesium sulfate infusion.
Topics: Anticonvulsants; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Muscle Weakness; Respiratory Insufficiency; Tetanus; Young Adult | 2010 |
[Drugs that may trigger or exacerbate myasthenia gravis].
Topics: Acetylcholine; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Aminoglycosides; Analgesics; Anesthetics; Anti-Infective Agents; Anticonvulsants; Botulinum Toxins; Contraindications; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lithium; Macrolides; Magnesium Sulfate; Muscle Weakness; Myasthenia Gravis; Neuromuscular Junction; Penicillamine; Receptors, Cholinergic; Vaccines | 2013 |